González GJL, Palacios MI, González VJA

Language: Spanish
References: 27
Page: 1-11
PDF size: 414.82 Kb.

ABSTRACT

Introduction: Hepatic hemangiomas are nonepithelial lesions much frequently observed in surgical specimens resected for other reasons. Hemangiomas ten centimeters or more, called "giant hemangiomas," can cause symptoms such as pain, as well as manifestations of an inflammatory reaction syndrome and coagulopathy. Hepatic hemangiomas are the commonest primary hepatic tumors, are present in 0.4-20% of the general population, and are typically accidentally detected during the evaluation of nonspecific abdominal symptoms.
Objective: To present the case of a patient with a giant hemangioma and unusual anatomical characteristics, who underwent surgery with good outcome and excellent evolution.
Clinical case: 24-year-old female patient with a giant hepatic hemangioma in the lateral segment, with a vascular anatomical variant that made embolization difficult and facilitated surgery. A left hepatic lobectomy was performed with satisfactory and uncomplicated clinical evolution.
Conclusions: Surgical resections of symptomatic giant hemangiomas are a safe and very valid therapeutic option in case of embolization failure.

REFERENCES

1. International Working P. Terminology of nodular hepatocellular lesions. Hepatology. 1995;22:983-93.

2. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-6.

3. Reddy KR, Schiff ER. Approach to a liver mass. Semin Liver Dis. 1993;13:423-35.

4. Bahirwani R, Reddy KR. Review article: the evaluation of solitary liver masses. Aliment Pharmacol Ther. 2008;28:953-65.

5. Rungsinaporn K, Phaisakamas T. Frequency of abnormalities detected by upper abdominal ultrasound. J Med Assoc Thai. 2008;91:1072-5.

6. Horta G, Lopez M, Dotte A, Cordero J, Chesta C, Castro A, et al. Benign focal liver lesions detected by computed tomography: review of 1,184 examinations. Rev Med Chil. 2015;143:197-202.

7. Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A, et al. Natural history ofhepatic haemangiomas: clinical and ultrasound study. Gut. 1991;32:677-80.

8. Glinkova V, Shevah O, Boaz M, Levine A, Shirin H. Hepatic haemangiomas: possible association with female sex hormones. Gut. 2004;53:1352-5.

9. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, MontaltoG, et al. Sex hormones and risk of liver tumor. Ann N Y Acad Sci. 2006;1089:228-36.

10. Hall GW. Kasabach-Merritt syndrome: pathogenesis and management. Br J Haematol. 2001;112:851-62.

11. O'Rafferty C, O'Regan GM, Irvine AD, Smith OP. Recent advances in the pathobiology and management of Kasabach-Merritt phenomenon. Br J Haematol. 2015;171:38-51.

12. Kim GE, Thung SN, Tsui WM, Ferrell LD. Hepatic cavernous hemangioma: underrecognized associated histologic features. Liver Int. 2006;26:334-8.

13. Wakasugi M, Ueshima S, Tei M, Tori M, Yoshida K, Tsujimoto M, et al. Multiple hepatic sclerosing hemangioma mimicking metastatic liver tumor successfully treated by laparoscopic surgery: report of a case. Int J Surg Case Rep. 2015;8C:137-40.

14. Quaia E, Bertolotto M, Dalla Palma L. Characterization of liver hemangiomas with pulse inversion harmonic imaging. Eur Radiol. 2002;12:537-44.

15. Itai Y, Ohtomo K, Furui S, Yamauchi T, Minami M, Yashiro N, et al. Noninvasive diagnosis of small cavernous hemangioma of the liver: advantage of MRI. AJR Am J Roentgenol 1985;145:1195-9.

16. Stark DD, Felder RC, Wittenberg J, Saini S, Butch RJ, White ME, et al. Magnetic imaging of cavernous hemangioma of the liver: tissue-specific characterization. AJR Am J Roentgenol. 1985;145:213-22.

17. Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, et al. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Radiology. 1994;192:401-6.

18. Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM, et al. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol. 2009;193:W490-6.

19. Danet IM, Semelka RC, Braga L, Armao D, Woosley JT. Giant hemangioma of the liver: MR imaging characteristics in 24 patients. Magn Reson Imaging. 2003;21:95-101.

20. Coumbaras M, Wendum D, Monnier-Cholley L, Dahan H, Tubiana JM, Arrive L, et al. CT and MR imaging features of pathologically proven atypical giant hemangiomas of the liver. AJR Am J Roentgenol. 2002;179:1457-63.

21. Hanafusa K, Ohashi I, Himeno Y, Suzuki S, Shibuya H. Hepatic hemangioma: findings with two-phase CT. Radiology. 1995;196:465-9.

22. Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, et al. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Eur J Radiol. 2012;81:2457-62.

23. Caldironi MW, Mazzucco M, Aldinio MT, Paccagnella D, Zani S, Pontini F, et al. Echo-guided fine-needle biopsy for the diagnosis of hepatic angioma. Areport on 114 cases. Minerva Chir. 1998;53:505-9.

24. Hasan HY, Hinshaw JL, Borman EJ, Gegios A, Leverson G, Winslow ER, et al. Assessing normal growth of hepatic hemangiomas during long-term follow-up. JAMA Surg. 2014;149:1266-71.

25. Groeschl RT, Riggle KM, Quebbeman EJ, Christians KK, Turaga KK, Tsai S, et al. Hepatectomy for hemangioma; safe, but is it successful? Hepatogastroenterology. 2014;61:2009-13.

26. Miura JT, Amini A, Schmocker R, Nichols S, Sukato D, Winslow ER, et al. Surgical management of hepatic hemangiomas: a multi-institutional experience. HPB (Oxford) 2014;16:924-8.

27. Ebina Y, Hazama R, Nishimoto M, Tanimura K, Miyahara Y, Morizane M, et al. Resection of giant liver hemangioma in a pregnant woman with coagulopathy: case report and literature review. J Prenatal Med. 2011;5:93-6.